Catheter Ablation Using a Novel Navigation and Imaging System

Not yet recruitingOBSERVATIONAL

Enrollment

100

Participants

Timeline

Start Date

December 1, 2025

Primary Completion Date

January 1, 2027

Study Completion Date

January 1, 2027

Conditions

Paroxysmal Atrial Fibrillation

Interventions

DEVICE

VERAFEYE System

VERAFEYE system guidance will be used on all patients undergoing PAF ablation.

All Listed Sponsors

lead

LUMA Vision Ltd.

INDUSTRY

NCT06895187 - Catheter Ablation Using a Novel Navigation and Imaging System | Biotech Hunter | Biotech Hunter